Investor Presentation

Date: November 06, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005 NSE Scrip Symbol: PARASHLTH Subject: Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, as amended, please find attached the Investor Presentation on Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. This Investor Presentation will also be hosted on the Company’s website at https://www.parashospitals.com/investors. We request you to kindly take the same on record. Thanking you. For Paras Healthcare Limited Rahul Kumar Company Secretary and Compliance Officer ICSI Membership No.: A20928 PPaarraass HHeeaalltthhccaarree LLiimmiitteedd TTwwoo DDeeccaaddeess ooff EExxcceelllleennccee 88 HHoossppiittaallss ((22 uuppccoommiinngg)) aaccrroossss 66 SSttaatteess aanndd 11 UUnniioonn TTeerrrriittoorryy TTaarrggeettiinngg 33,,001111 BBeeddss bbyy 22002288 Investor Presentation Investor Presentation Q2 & H1 FY27 Q2 & H1 FY27 OOuurr HHoossppiittaallss :: GGuurruuggrraamm,, PPaattnnaa,, DDaarrbbhhaannggaa,, PPaanncchhkkuullaa,, RRaanncchhii,, UUddaaiippuurr,, SSrriinnaaggaarr aanndd KKaannppuurr UUppccoommiinngg HHoossppiittaallss :: GGuurruuggrraamm--GGoollff CCoouurrssee EExxtteennssiioonn aanndd LLuuddhhiiaannaa Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Paras Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness Paras Healthcare Limited 2 Q2 & H1FY27 Operational & Financial Highlights Q2 FY27 Vs Q2 FY 26: Momentum Across Revenue and Profits INR 510.9 +22.8% Revenue YoY Growth vs INR 416.1 Crs INR 120.2 Crs 23.5% | 19.6% +47.0% Op. EBITDA Op. EBITDA Margins (Excl other income) vs INR 81.7 Crs YoY Growth growth of 390 bps Reported INR 126.6 Crs 24.5% | 21.0% +42.5% EBITDA Reported EBITDA Margins (incl other income) vs INR 88.8 Crs YoY Growth growth of 350 bps INR 40.4 Crs 7.8% | 2.9% 3.3x PAT Margins vs INR 12.4 Crs YoY Growth growth of 490 bps Paras Healthcare Limited 4 H1 FY27 vs H1 FY26 : Growth Compounding into Profitability INR 981.2 +25.1% Revenue YoY Growth vs INR 784.5 Crs INR 225.2 Crs 23.0% | 18.1 % +58.4% Op. EBITDA Op. EBITDA Margins (Excl other income) vs INR 142.2 Crs YoY Growth growth of 480 bps Reported INR 240.1 Crs 24.1% | 19.5 % +54.7% EBITDA Reported EBITDA Margins (incl other income) vs INR 155.2 Crs YoY Growth growth of 465 bps INR 90.0 9.0% 7.9x PAT Margins vs 1.4% in H1 FY26, vs INR 11.4 Crs YoY Growth growth of 760 bps Paras Healthcare Limited 5 Operating Leverage in Action Revenue from Operations (Rs. in Crs) Operating EBITDA & Margin % 19.6% 23.5% 18.1% 23.0% 981.2 784.5 225.2 510.9 142.2 416.1 120.2 81.7 Q2FY26 Q2FY27 H1FY26 H1FY27 Q2FY26 Q2FY27 H1FY26 H1FY27 47.0% 58.4% 22.8% 25.1% YoY EBITDA Growth YoY EBITDA Growth YoY Revenue Growth YoY Revenue Growth Q2FY27 vs Q2FY26 H1FY27 vs H1FY26 Q2FY27 vs Q2FY26 H1FY27 vs H1FY26 Paras Healthcare Limited 6 Our Hospital Cohorts : FY26 Mature (>7 years) – 1,076 Beds Emerging (4–7 years) – 500 Beds New (<4 years) – 635 Beds Gurugram Patna Ranchi Udaipur Srinagar Kanpur Darbhanga Panchkula FY26 Revenue ₹1,179 Cr FY26 Revenue ₹283 Cr FY26 Revenue ₹144 Cr Op. EBITDA Op. EBITDA Op. EBITDA ~26% ~15% NM Margin Margin Margin Occupancy 73.2% Occupancy 57.8% Occupancy 33.8% Stable and growing occupancy levels, strong Shown improving occupancy and margin Op. EBITDA improved by ₹51.7 Cr(1). Expected to clinical reputation and consistent margin expansion as their scale of operations builds follow a similar growth trajectory through expansion occupancy improvement, addition of specialties and op. leverage. Note: (1) From FY25 to FY26. Paras Healthcare Limited 7 OUR HOSPITAL COHORTS Q2 FY27: Newer hospitals ramp up continues Mature Hospitals (> 7 years) Emerging Hospitals (4 to 7 years) New Hospitals (< 4 years) Revenue from Operations (Rs. in Crs) 76.2% 78.1% 53.4% 70.3% 34.4% 78.1% 8.5% 27.2% 138.8% 91.7 84.4 308.7 334.8 72.1 35.3 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Operating EBITDA & Margin % (Rs. in Crs) 26.0% 29.6% 16.2% 18.5% n.m. 18.7% 23.1% 45.8% 98.9 17.0 15.8 80.4 11.7 (3.1) Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Note: Cohort Operating EBITDA is at hospital level, before corporate overheads, so cohorts do not add up Bed Occupancy Rate (%) Operating EBITDA Margin (%) to consolidated Operating EBITDA. Paras Healthcare Limited 8 OUR HOSPITAL COHORTS H1 FY27: Newer hospitals moving to “Emerging” Mature Hospitals (> 7 years) Emerging Hospitals (4 to 7 years) New Hospitals (< 4 years) Revenue from Operations (Rs. in Crs) 74.0% 76.5% 49.1% 68.6% 27.8% 68.4% 9.1% 43.2% 147.1% 651.5 183.4 146.3 597.2 128.1 59.2 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 Operating EBITDA & Margin % (Rs. in Crs) 25.6% 28.9% 12.4% 18.3% n.m. 17.5% 23.1% 110.9% 188.4 33.5 25.6 153.0 15.9 (13.3) H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 Note: Cohort Operating EBITDA is at hospital level, before corporate overheads, so cohorts do not add up Bed Occupancy Rate (%) Operating EBITDA Margin (%) to consolidated Operating EBITDA. Par [Showing first 8,000 characters — download PDF for full document]